These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


149 related items for PubMed ID: 1600993

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo].
    Hopf R, Drews H, Kaltenbach M.
    Z Kardiol; 1984 Sep; 73(9):578-85. PubMed ID: 6391005
    [Abstract] [Full Text] [Related]

  • 3. Comparison of dihydropyridine and phenylalkylamine calcium antagonists in patients with coronary heart disease.
    Rettig GF, Jakob M, Sen S, Heisel A.
    Drugs; 1991 Sep; 42 Suppl 1():37-43. PubMed ID: 1718693
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The anti-ischemic effect of gallopamil-retard in comparison with nifedipine-retard in stable angina pectoris].
    Rettig GF, Jakob M, Koch HP.
    Z Kardiol; 1992 Oct; 81(10):525-30. PubMed ID: 1441691
    [Abstract] [Full Text] [Related]

  • 6. Comparative study of gallopamil versus nifedipine in patients with ischemic heart disease.
    Molinero De Miguel E, Salcedo Arruti A, Sagastagoitia Gorostiza JD, Iriarte Ezkurdia MM, Fernandez Vidal P, Velasco Quintana J, Garrido García J.
    Int J Cardiol; 1993 Jul 01; 40(2):127-33. PubMed ID: 8349375
    [Abstract] [Full Text] [Related]

  • 7. Effect of gallopamil on myocardial microperfusion in patients with stable effort angina: a randomized, cross-over, double-blind, placebo-controlled trial.
    Acanfora D, Vitale DF, Rengo C, Iannuzzi GL, Furgi G, Picone C, Rossi M, Trojano L, Rengo F.
    Cardiology; 1997 Jul 01; 88(4):353-60. PubMed ID: 9197430
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gallopamil in chronic stable angina: antianginal effect and mechanism of action. A randomized, placebo-controlled, double-blind, cross-over trial.
    Zanolla L, Carbonieri E, Rossi L, Marino P, Zardini P.
    Cardiology; 1992 Jul 01; 80(5-6):324-31. PubMed ID: 1451119
    [Abstract] [Full Text] [Related]

  • 11. [Therapeutic coronary effectiveness of retard gallopamil following repeated administration in comparison with placebo].
    Loskot F, Novotny P, Sucic P, Schneider G.
    Z Kardiol; 1989 Jul 01; 78 Suppl 5():89-93. PubMed ID: 2698569
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of acute and steady-state conditions of gallopamil therapy in stable angina pectoris.
    Vilchez FG, Villarroel T, Ruano Calvo J, Vazquez de Prada JA, Martin-Duran R, San Jose JM, Pajaron A.
    Int J Cardiol; 1992 Oct 01; 37(1):91-9. PubMed ID: 1428294
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
    Ulvenstam G, Diderholm E, Frithz G, Gudbrandsson T, Hedbäck B, Höglund C, Moelstad P, Perk J, Sverrisson JT.
    J Cardiovasc Pharmacol; 1992 Oct 01; 20 Suppl 3():S67-73. PubMed ID: 1282179
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of slow-release gallopamil in patients with stable exercise-inducible angina pectoris.
    Kottkamp H, Gülker H, Emmerich K, Koch HP, Minge C.
    J Cardiovasc Pharmacol; 1992 Oct 01; 20 Suppl 7():S88-94. PubMed ID: 1284163
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.